Laddar...
Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?
The unprecedented clinical activity of checkpoint blockade in several types of cancers has formally demonstrated that anti-tumor immune responses are crucial in cancer therapy. Durable responses seen in patients treated with immune checkpoint inhibitors (ICI) show that they can trigger the establish...
Sparad:
| I publikationen: | Front Immunol |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6548803/ https://ncbi.nlm.nih.gov/pubmed/31191545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01181 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|